DK3862015T3 - Peptider til anvendelse ved behandling af inflammatorisk colitis - Google Patents

Peptider til anvendelse ved behandling af inflammatorisk colitis Download PDF

Info

Publication number
DK3862015T3
DK3862015T3 DK19855142.6T DK19855142T DK3862015T3 DK 3862015 T3 DK3862015 T3 DK 3862015T3 DK 19855142 T DK19855142 T DK 19855142T DK 3862015 T3 DK3862015 T3 DK 3862015T3
Authority
DK
Denmark
Prior art keywords
peptides
treatment
inflammatory colitis
colitis
inflammatory
Prior art date
Application number
DK19855142.6T
Other languages
English (en)
Inventor
Yoon Jeong Park
Chong-Pyoung Chung
Jue-Yeon Lee
Original Assignee
Nibec Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nibec Co Ltd filed Critical Nibec Co Ltd
Priority claimed from PCT/KR2019/011037 external-priority patent/WO2020046002A1/ko
Application granted granted Critical
Publication of DK3862015T3 publication Critical patent/DK3862015T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK19855142.6T 2018-08-31 2019-08-29 Peptider til anvendelse ved behandling af inflammatorisk colitis DK3862015T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20180103615 2018-08-31
KR1020190105917A KR102244161B1 (ko) 2018-08-31 2019-08-28 다중의 질환 바이오마커의 기능 및 발현을 억제하는 펩타이드의 신규한 용도
PCT/KR2019/011037 WO2020046002A1 (ko) 2018-08-31 2019-08-29 다중의 질환 바이오마커의 기능 및 발현을 억제하는 펩타이드의 신규한 용도

Publications (1)

Publication Number Publication Date
DK3862015T3 true DK3862015T3 (da) 2024-04-22

Family

ID=69800621

Family Applications (2)

Application Number Title Priority Date Filing Date
DK23151983.6T DK4218788T3 (da) 2018-08-31 2019-08-29 Peptider til anvendelse ved behandling af ikke-alkoholisk steatohepatitis
DK19855142.6T DK3862015T3 (da) 2018-08-31 2019-08-29 Peptider til anvendelse ved behandling af inflammatorisk colitis

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK23151983.6T DK4218788T3 (da) 2018-08-31 2019-08-29 Peptider til anvendelse ved behandling af ikke-alkoholisk steatohepatitis

Country Status (5)

Country Link
US (2) US20210340182A1 (da)
EP (2) EP3862015B1 (da)
KR (1) KR102244161B1 (da)
CN (1) CN112912093B (da)
DK (2) DK4218788T3 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116135874B (zh) * 2021-11-18 2025-07-25 深圳碳云智肽药物科技有限公司 靶向hdac5的多肽及其在制备用于治疗癌症的药物中的应用
CN115737616B (zh) * 2021-11-29 2024-06-07 南方医科大学南方医院 Lmk-235在医学中的新应用
CN116947967B (zh) * 2022-04-18 2025-07-25 深圳碳云智肽药物科技有限公司 靶向hdac5的多肽及其在制备治疗或预防个体肿瘤的制剂上的应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002040512A2 (de) * 2000-11-14 2002-05-23 Ipf Pharmaceuticals Gmbh Humanes beta-defensin-3
US8232248B2 (en) * 2008-07-18 2012-07-31 Novozymes Adenium Biotech A/S Treatment of rheumatoid arthritis with mammal beta defensins
SG172709A1 (en) * 2008-07-18 2011-07-28 Novozymes Adenium Biotech As Treatment of inflammatory bowel diseases with mammal beta defensins
AP2011005537A0 (en) 2008-07-18 2011-02-28 Novozymes Adenium Biotech As Treatment of inflammatory diseases with mammal beta defensins.
US8362218B2 (en) * 2009-04-17 2013-01-29 New York University School Of Medicine Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof
KR101329774B1 (ko) * 2010-06-16 2013-11-15 주식회사 나이벡 항균 또는 항염증 활성을 가지는 펩타이드 및 이를 유효성분으로 함유하는 약제학적 조성물
JP6219277B2 (ja) * 2011-07-08 2017-10-25 ディフェンシン セラピューティクス アンパルトセルスカブＤｅｆｅｎｓｉｎ Ｔｈｅｒａｐｅｕｔｉｃｓ Ａｐｓ 炎症性腸疾患の経口治療
KR101693533B1 (ko) 2015-03-26 2017-01-06 서울대학교산학협력단 암줄기세포의 성장억제용 항암기능성 펩타이드 및 그 용도
KR101906557B1 (ko) 2015-08-06 2018-10-11 서울대학교산학협력단 합성 펩타이드를 이용한 유도만능줄기세포의 제조방법
CN105288590A (zh) * 2015-11-03 2016-02-03 昆明理工大学 一种人防御素蛋白的新用途
CN109414474B (zh) * 2016-04-29 2024-07-02 诺维信公司 肝脏、胆道和胰腺障碍的治疗
KR101979932B1 (ko) * 2017-08-18 2019-05-21 서울대학교산학협력단 골 흡수 억제용 펩타이드
MX2020004863A (es) * 2017-11-10 2020-10-14 Defensin Therapeutics Aps Maduracion de la defensa de la mucosa y/o funcion intestinal/pulmonar en el bebe prematuro.
PL3713590T3 (pl) * 2017-11-24 2025-09-15 Defensin Therapeutics Aps Ludzka beta 2 defensyna do stosowania w zapobieganiu i leczeniu choroby przeszczep przeciwko gospodarzowi
KR102631543B1 (ko) * 2018-03-14 2024-02-01 서울대학교산학협력단 세포 투과능 및 근육 재생능을 가지는 이중 기능성 펩타이드 및 이의 용도
KR102631542B1 (ko) * 2018-03-14 2024-02-01 서울대학교산학협력단 염증 감소능 및 줄기세포로부터 연골세포로의 분화 촉진능을 가지는 이중 기능성 펩타이드 및 이의 용도
WO2020046001A1 (ko) * 2018-08-31 2020-03-05 주식회사 나이벡 염증 및 대사성 질환의 바이오마커에 대한 결합능이 있는 신규한 펩타이드 및 이의 용도

Also Published As

Publication number Publication date
KR20200026122A (ko) 2020-03-10
EP3862015A1 (en) 2021-08-11
EP3862015A4 (en) 2022-07-06
EP4218788A1 (en) 2023-08-02
US20240166688A1 (en) 2024-05-23
DK4218788T3 (da) 2024-10-28
EP3862015B1 (en) 2024-03-13
EP4218788B1 (en) 2024-08-14
CN112912093A (zh) 2021-06-04
CN112912093B (zh) 2024-11-15
US20210340182A1 (en) 2021-11-04
KR102244161B1 (ko) 2021-04-26
US12486303B2 (en) 2025-12-02

Similar Documents

Publication Publication Date Title
HUS2500039I1 (hu) Elafibranor primer biliáris cirrózis kezelésében történõ alkalmazásra
DK3501542T3 (da) Esketamin til behandling af depression
DK3490582T3 (da) Sammensætninger til anvendelse i behandling af myelofibrose
DK3668509T3 (da) Fremgangsmåde til behandling af amyotrofisk lateralsklerose med pridopidin
DK3185957T3 (da) Patisiran til anvendelse ved behandlingen af transthyretin-medieret amyloidosis
DK3612215T3 (da) Sammensætninger til behandling af lungeinflammation
DK3240554T3 (da) Blautia stercosis og wexlerae til anvendelse til behandling af inflammatoriske og autoimmune sygdomme
DK3096798T3 (da) Plasmakallikreinbindende proteiner og anvendelser deraf til behandling af hereditært angioødem
DK4327866T3 (da) Mirikizumab ved behandling af ulcerøs kolitis
DK3197472T3 (da) Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri
DK3119797T3 (da) Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose
DK3713554T3 (da) Doseringsanvisninger for vidofludimus til behandling af kroniske inflammatoriske og/eller autoimmunsygdomme
DK3504187T3 (da) Anvendelse af pridopidin til behandling af funktionel tilbagegang
DK3481846T3 (da) 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande
DK3307296T3 (da) Timp2 til anvendelse til behandling af aldringsassocierede tilstande
DK3865484T3 (da) Pde9-hæmmer med imidazopyrazinon-rygrad til behandling af perifere sygdomme
DK3710000T3 (da) Tradipitant til anvendelse til behandling af gastroparese
DK3149049T3 (da) Il-22 til anvendelse til behandling af stofskiftesygdomme
DK4008329T3 (da) Isoxazolinforbindelser til anvendelse i behandling af demodicose
DK3551189T3 (da) Alprazolam til anvendelse ved behandling af epilepsi
DK3556383T3 (da) Plasminogen til anvendelse ved behandling af diabetes
DK3331610T3 (da) Midler til anvendelse til behandling af gliom
DK3344655T3 (da) Brug af anti-cd40-antistoffer til behandling af lupus nefritis
DK3658133T3 (da) Sammensætninger omfattende aminosyrer til anvendelse ved behandling af fedme
DK3618845T3 (da) Peptider til behandling af diabetes